新华财经上海11月23日电 （谷青竹） 小雪时节，暖意融融。11月22日，由宝山区卫生健康委员会联合 庙行镇党委、政府共同打造的"YOUNG生'庙'会"国潮中医市集，在共康党群服务中心东茭泾畔鸣锣开 市。这场为期两天的市集以"中医生活化、年轻化、本土化"为核心，将中医"治未病"理念与潮流体验深 度融合，让居民在逛市集、享服务中感受中医魅力，成为宝山区党建与卫生健康事业深度融合的生动实 践。 生活化落地：服务触手可及，健康融入日常 市集以"便民惠民"为核心，将专业中医服务转化为居民触手可及的生活体验。曙光医院、宝山区中西医 结合医院等多家医疗机构的专家坐镇咨询区，针对颈肩腰腿痛、失眠、消化不适等常见问题提供一对一 解答；基础检测区免费提供血压、血糖测量和体质辨识服务，耳穴贴压、艾灸贴DIY等适宜技术体验区 前排起长队；八段锦现场教学环节更是人气爆棚，老祖宗传下来的养生功法成为打工人"去班味"的实用 妙招。 "在家门口就能找专家咨询，还能免费测血压、学养生功法，这样的市集太实用了！"居民杨红卫阿姨特 意赶来参与市集。作为中医的忠实粉丝，她深有感触："大病术后调理、日常养生保健，中医都帮了大 忙，西医治标、中医固本 ...

Investment Rating - The report assigns an "Outperform" rating to Gushengtang, expecting a relative return exceeding 10% over the next 12-18 months [16]. Core Insights - Gushengtang announced the acquisition of 100% equity in Singapore's Da Zhong Tang, which operates 14 TCM clinics, aiming to enhance its market share and expand its business network in Singapore [5][6]. - The acquisition is anticipated to positively impact the company's performance in 2026, leveraging Da Zhong Tang's established brand and operational presence in key commercial areas of Singapore [6][7]. - The company plans to continue its overseas expansion through a combination of mergers and acquisitions, partnerships, and self-established clinics, targeting the addition of 10-20 new stores in Singapore and around 20 clinics in Hong Kong by 2026 [7][8]. Summary by Sections Acquisition Details - Gushengtang's acquisition of Da Zhong Tang will consolidate its financial results into the group's statements, enhancing its operational scale in Singapore [5][6]. Market Expansion Strategy - The company aims to expand its presence in Singapore through a mix of M&A, partnerships, and new clinic establishments, with a goal of generating significant overseas revenue by 2026 [7]. Operational Enhancements - Gushengtang plans to utilize its domestic supply chain for Chinese herbal products to support its overseas clinics, while enhancing internal treatment capabilities through AI technology and expert training [8].

固生堂 2024 年收入约 800 万新币，2025 年至今保持超 100%增长， 通过并购、合作、自建积极扩展海外市场，控股 OneDox 实现中西医结 合，收购大中堂增强市场控制力，新加坡首店月收入达 16-17 万新币， 回头率超 40%。 固生堂董事长持续增持公司股份，看好公司未来发展。国内市场方面， 2024 年以利润为主导，2025 年上半年利润增长显著。无锡地区在医保 政策严格管控下收入增长超 40%，区域利润率约 26%，显示出盈利能 力。 固生堂计划 2026 年进入香港和马来西亚市场，香港通过并购增加约 20 家诊所。公司人才策略是将中国优秀人才派驻海外担任总经理，构建本 地化运营团队，力争三年内成为当地中医领域头部企业。 新加坡中医支付主要依赖自费，但正推动中医药沙盒计划，未来可能纳 入医保体系。香港医疗券可用于中医诊所，商业保险也覆盖部分。公司 预计 2026 年海外收入规模将达数亿元人民币。 Q&A 固生堂 20251117 摘要 固生堂在新加坡的并购进展和战略布局是怎样的？ 固生堂于 2025 年 10 月与新加坡数字医疗平台 OneDox 达成战略合作，并在 2025 年 11 ...

Core Viewpoint - Gushengtang Singapore TCM Healthcare Technologies Holdings Private Limited has entered into a share transfer agreement to acquire 100% equity and related interests of DA ZHONG TANG PTE. LTD., which will become a subsidiary of the company after the completion of the acquisition [1] Group 1 - The acquisition is set to be completed on November 16, 2025, marking a significant expansion for the company [1] - Following the acquisition, the financial performance of DA ZHONG TANG will be consolidated into the group's financial statements [1]

Core Viewpoint - Gushengtang Singapore TCM Healthcare Technologies Holdings Private Limited, a subsidiary of Gushengtang, has entered into a share transfer agreement to acquire 100% equity and related interests of DA ZHONG TANG PTE.LTD., which will become a subsidiary of the company upon completion of the acquisition [1] Group 1: Acquisition Details - The acquisition is part of the company's strategy to expand its offline medical institution network, aiming to increase market share in Singapore and create synergies with other offline medical institutions and online medical platforms [1] - The acquisition price was determined through fair negotiations between Gushengtang Singapore and the seller, taking into account DA ZHONG TANG's historical performance, qualifications, resources, and prospects [1] - The board believes the acquisition price represents a fair and reasonable valuation for DA ZHONG TANG [1] Group 2: Financial Implications - The acquisition cost will be funded through the net proceeds from the company's placement, idle funds of the group, and Gushengtang Singapore's own funds [1]

Core Viewpoint - Gushengtang Singapore is set to acquire 100% equity and related interests of DA ZHONG TANG PTE. LTD., which will become a subsidiary of the company, enhancing its market presence in Singapore and creating synergies with existing healthcare platforms [1][2] Group 1 - The acquisition agreement was established on November 16, 2025, and will integrate DA ZHONG TANG's financial performance into Gushengtang's consolidated financial statements [1] - The acquisition aligns with the company's strategy to expand its offline medical institution network and increase market share in Singapore [1] - The financial terms of the acquisition were determined through fair negotiations, considering DA ZHONG TANG's historical performance, qualifications, resources, and prospects [2] Group 2 - The acquisition cost will be funded through net proceeds from a placement, idle funds of the group, and Gushengtang Singapore's own capital [2]

Core Viewpoint - Gushengtang Singapore is acquiring 100% equity and related interests of DA ZHONG TANG PTE. LTD., which will become a subsidiary of the company, enhancing its presence in the Singapore market and expanding its offline medical network [1] Group 1 - The acquisition agreement was signed on November 16, 2025, between Gushengtang Singapore and the shareholders of DA ZHONG TANG [1] - Following the completion of the acquisition, DA ZHONG TANG will be included in the group's consolidated financial statements [1] - DA ZHONG TANG primarily provides traditional Chinese medicine services and retail pharmaceutical services in Singapore [1] Group 2 - The acquisition aligns with the company's strategy to expand its offline medical institution network through acquisitions [1] - The company anticipates that the acquisition will increase its market share in Singapore and create synergies between DA ZHONG TANG and the group's other offline medical institutions and online medical platforms [1]

Core Viewpoint - The establishment of the "Renhe Academy" by the Zhejiang Provincial Institute of Traditional Chinese Medicine marks a significant step in the cultivation of traditional Chinese medicine (TCM) talent, aiming to create a leading TCM classic academy in China [1][2]. Group 1: Academy Establishment - The "Renhe Academy" was inaugurated with the participation of renowned TCM experts, who were appointed as academic advisors and professors, forming a strong mentorship team [1]. - The academy aims to deepen the "group teacher leads group apprentice" model in Zhejiang, serving as an important practical platform for TCM talent development [1]. Group 2: Educational Activities - The academy plans to regularly host events such as the "National Medicine Lecture Hall," master consultations, and classic studies, focusing on a comprehensive training approach that integrates various schools and disciplines [2]. - The first lecture of the "National Medicine Lecture Hall" was well-attended, indicating strong interest in TCM education [1]. Group 3: Cultural Integration - The academy organized a calligraphy exhibition of TCM prescriptions, showcasing the unique charm of the integration of TCM culture and calligraphy art, with a total of 207 prescriptions collected for the exhibition [1]. - The exhibition will tour various branches of the provincial TCM research institute, further promoting TCM culture [1].

Core Viewpoint - The academic annual meeting of the Acupuncture and Meridians Professional Committee of the Weihai Traditional Chinese Medicine Association successfully took place, focusing on the diagnosis and treatment of shoulder joint disorders, highlighting the integration of traditional Chinese medicine with modern practices [1] Group 1: Event Overview - The event was held on October 18 at the Rongcheng Traditional Chinese Medicine Hospital, featuring academic lectures from experts in acupuncture and traditional Chinese medicine [1] - Over 60 medical professionals specializing in acupuncture and related fields attended the training, indicating strong interest and engagement in the subject matter [1] Group 2: Expert Contributions - Professors Li Yongchun and Li Huadong from Shandong University of Traditional Chinese Medicine, along with directors Zhang Yuxin and Yuan Wenjie from Rongcheng Hospital, provided in-depth academic insights on various shoulder joint disorders [1] - Topics covered included frozen shoulder, shoulder joint disorders, rotator cuff injuries, and shoulder joint exercises, combining practical and theoretical knowledge [1] Group 3: Training Outcomes - The training expanded the clinical diagnostic and treatment perspectives for attendees, enriching the methods of integrating traditional Chinese and Western medicine [1] - The event aimed to strengthen the theoretical foundation and practical skills in the field of traditional Chinese medicine, contributing to the standardization of acupuncture practices and better meeting public health needs [1]

Core Insights - The Hansa Mei'an Traditional Chinese Medicine Center in Hamburg celebrated its 15th anniversary, marking significant achievements in research, education, clinical practice, and international collaboration, serving as a model for the development of TCM in the European healthcare system [1][2] Group 1: Establishment and Achievements - The Hansa Mei'an TCM Center was established in 2010 as the first specialized TCM institution within the German university hospital system [1] - Over the past 15 years, the center has served more than 30,000 patients and published approximately 70 academic papers in international journals, gaining attention from the global medical community [2] Group 2: Cultural and Collaborative Impact - The establishment of the center reflects the fruitful relationship between Shanghai and Hamburg, symbolizing practical cooperation between China and Germany [1] - Research is deemed crucial for the development of TCM in Europe, with ongoing collaborations between TCM research institutions in Hamburg, Shanghai, and Hefei showing steady progress [1] Group 3: Future Focus - The center aims to continue focusing on the integration of Chinese and Western medicine, international standardization, and the cultivation of cross-cultural medical talent [1]